Coccia, P. A., Alconcher, L. F., Ferraris, V., Lucarelli, L. I., Grillo, M. A., Arias, M. A., . . . Sánchez-Luceros, A. (2025). Eculizumab as first-line treatment for patients with severe presentation of complement factor H antibody–mediated hemolytic uremic syndrome. Pediatric Nephrology, 40(4), 1041-1048.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
Coccia, Paula A., et al. "Eculizumab as First-line Treatment for Patients with Severe Presentation of Complement Factor H Antibody–mediated Hemolytic Uremic Syndrome."
Pediatric Nephrology 40, no. 4 (2025): 1041-1048.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
Coccia, Paula A., et al. "Eculizumab as First-line Treatment for Patients with Severe Presentation of Complement Factor H Antibody–mediated Hemolytic Uremic Syndrome."
Pediatric Nephrology, vol. 40, no. 4, 2025, pp. 1041-1048.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.